Department of Pulmonary and Critical Care Medicine, Yale New Haven Health, Lawrence + Memorial Hospital, New London, CT 06320, USA.
Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Adv Respir Med. 2023 Mar 10;91(2):123-134. doi: 10.3390/arm91020011.
Patients with COPD (chronic obstructive pulmonary disease) are at a higher risk of comorbid conditions such as anxiety and/or depression, which in turn increase their symptom burden and rehospitalizations compared to the general population. It is important to investigate the pathophysiology and clinical implications of mental health on patients with COPD. This review article finds that COPD patients with anxiety and/or depression have a higher rehospitalization incidence. It reviews the current screening and diagnosis methods available. There are pharmacological and non-pharmacologic interventions available for treatment of COPD patients with depression based on severity. COPD patients with mild depression benefit from pulmonary rehabilitation and cognitive behavioral therapy, whereas patients with severe or persistent depression can be treated with pharmacologic interventions.
COPD(慢性阻塞性肺疾病)患者患合并症(如焦虑和/或抑郁)的风险较高,与普通人群相比,他们的症状负担和再住院率更高。研究心理健康对 COPD 患者的病理生理学和临床意义非常重要。这篇综述文章发现,焦虑和/或抑郁的 COPD 患者再住院的发生率更高。文章回顾了现有的筛查和诊断方法。对于不同严重程度的抑郁 COPD 患者,可以采用药物和非药物干预的方法进行治疗。轻度抑郁的 COPD 患者可以从肺康复和认知行为疗法中获益,而对于重度或持续性抑郁的患者可以采用药物干预的方法进行治疗。